Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2018 Aug;8(4):964–984. doi: 10.1007/s13346-017-0419-y

Table 3.

Size and surface charge of PEG-PLGA NPs encapsulating DOX, formulated with DMAB as the emulsion stabilizer (n=3 replicate formulations; mean ± st. dev)

1% DMAB PEG-PLGA Size (nm) Charge (mV) DOX Encapsulation (%)
0% w/w DOX 254.5 ± 36.8 24.2 ± 2.4 N/A
2% w/w DOX 246.1 ± 4.4 21.8 ± 3.0 72.95 ± 4.5
5% w/w DOX 285.9 ± 14.9 25.1 ± 2.0 82.11 ± 1.0
10% w/w DOX 269.8 ± 31.7 23.5 ± 5.8 87.42 ± 2.3